Literature DB >> 1356052

Thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies during the pregnancy and postpartum period: a case report.

S Yoshida1, J Takamatsu, K Kuma, N Ohsawa.   

Abstract

This report describes a unique pattern of changes in thyroid function and thyroid antibodies in a woman during the course of two pregnancies and two postpartum periods. A 25-year-old woman developed hypothyroidism in the postpartum period after the delivery of her first child. She was found to have potent thyroid stimulation-blocking antibodies (TSBAb) in the serum. One year later, she became pregnant again, and during the pregnancy, TSBAb had decreased to an undetectable level. She gave birth to the second healthy child and developed postpartum thyrotoxicosis, probably due to destruction of the thyroid gland, which gradually resolved. In this postpartum period, serum TSBAb levels increased. Eight months postpartum, she developed what appeared to be Graves' disease with an elevated 123I-thyroid uptake. Serum thyroid-stimulating antibodies (TSAb) were found at that time, and the TSBAb had disappeared from her serum.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356052     DOI: 10.1089/thy.1992.2.27

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  2 in total

1.  Brief Report - Monoclonal Antibodies Illustrate the Difficulties in Measuring Blocking TSH Receptor Antibodies.

Authors:  Terry F Davies; Syed A Morshed; Mihaly Mezei; Rauf Latif
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-15       Impact factor: 6.055

Review 2.  The Clinical Value and Variation of Antithyroid Antibodies during Pregnancy.

Authors:  Chuyu Li; Jing Zhou; Zengshu Huang; Xinyao Pan; Wingting Leung; Lijia Chen; Yanzhi Zhang; Lan Wang; Yizhen Sima; Hans-Jürgen Gober; Na Zhang; Xuemin Qiu; Lisha Li; Liang Guan; Ling Wang
Journal:  Dis Markers       Date:  2020-10-21       Impact factor: 3.434

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.